(Press-News.org) Brain tumor cells with a certain common mutation reprogram invading immune cells. This leads to the paralysis of the body's immune defense against the tumor in the brain. Researchers from Heidelberg, Mannheim, and Freiburg discovered this mechanism and at the same time identified a way of reactivating the paralyzed immune system to fight the tumor. These results confirm that therapeutic vaccines or immunotherapies are more effective against brain tumors if active substances are simultaneously used to promote the suppressed immune system.
Diffuse gliomas are usually incurable brain tumors that spread in the brain and are difficult to completely remove by surgery. Chemotherapy and radiotherapy often only have a limited effect too. Oncologists are thus urgently trying to find innovative treatment approaches to fight the gliomas using the immune system - by means of therapeutic vaccines or immunotherapies.
Gliomas do not consist entirely of cancer cells: up to 50% of the tumor mass is made up of microglia cells - the brain's own phagocytes - and of macrophages that enter the tumor through the blood vessels. Macrophages are also scavenger cells, but they are not effective in fighting tumor cells.
"If we are to make progress in developing immunotherapies or therapeutic vaccines, we need to understand exactly how the immune environment behaves during tumor development. Moreover, we were interested in whether special genetic features of the gliomas have a particular influence on the function of the glioma-associated immune cells," explained Michael Platten, Director of the Department of Neurology of University Medicine Mannheim, Head of Division at the German Cancer Research Center (DKFZ), and director of the current study.
Scientists from Platten's division have now teamed up with Marco Prinz, Medical Director of the Institute of Neuropathology in Freiburg, and his working group to publish a molecular "status analysis" of the glioma-associated immune cells. To do so, they specifically studied the RNA and protein profiles of individual microglia cells and macrophages. Using tumor models in mice, they were also able to demonstrate the development of the immune environment over the course of the disease.
Metabolic product of the glioma cells paralyzes immune cells in the brain
The researchers were particularly interested in tumors with what is known as an IDH mutation, which is found in around 70% of all low-grade gliomas. These tumor cells have an identical mutation that leads to a particular protein building block being exchanged in the IDH* enzyme.
As a result of the IDH mutation, the glioma cells release the cancer-promoting metabolic product (R)-2-HG, which, as the researchers discovered, affects the invading macrophages. These scavenger cells are reprogrammed as it were, blocking an immune response against the tumor: they release messenger substances that suppress the immune system and inhibit T cell activity - researcher refer to this as "immune paralysis". "Ultimately, the IDH mutation enables the gliomas to protect themselves against the human immune system," explained Mirco Friedrich, DKFZ researcher and physician at Heidelberg University Hospital, one of the lead authors of the current publication.
The researchers were subsequently able to decipher the molecular mechanism by which (R)-2-HG reprograms the macrophages: the cancer-promoting metabolic product interferes with the amino acid metabolism of the scavenger cells. This leads to activation of a central immune system regulatory molecule, aryl hydrocarbon receptor. The activated receptor causes immunosuppression of the macrophages.
Reactivating the paralyzed immune system
In view of this central role of the aryl hydrocarbon receptor, the researchers decided to specifically deactivate the function of this key molecule. To do so, they used a specific substance co-developed by DKFZ and Bayer. They combined this substance with a special immunotherapy, known as an immune checkpoint inhibitor. This immunotherapy is normally ineffective, but the combination rendered it effective in an animal model and prolonged the lives of the mice with IDH-mutant tumors.
"For the first time, we have thus demonstrated that the 'paralyzed' glioma-associated scavenger cells can be specifically reactivated by drugs in IDH-mutant gliomas," Mirco Friedrich remarked. "The work is a good example of how single cell studies can lead to a treatment mechanism," added Roman Sankowski from Freiburg University Hospital.
As Lukas Bunse, a physician at DKFZ and Mannheim University Medicine, explained, "We were recently able to prove in an early clinical study that a therapeutic vaccination** against IDH-mutant diffuse gliomas triggers the desired immune response in the study subjects. Our current studies now demonstrate how to sidestep the immunosuppressive environment in the brain and improve the effectiveness of this vaccine even further. This is an encouraging result showing that the immune system can help fight this currently almost incurable disease more effectively." Clinical studies will now be conducted to reveal whether this treatment strategy is a promising option for glioma patients.
INFORMATION:
* IDH = isocitrate dehydrogenase
** Michael Platten et al., A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature 2021, DOI: https://dx.doi.org/10.1038/s41586-021-03363-z
https://www.dkfz.de/en/presse/pressemitteilungen/2021/dkfz-pm-21-17-Vaccination-against-mutated-protein-tested-in-brain-tumor-patients-for-the-first-time.php
Current publication:
Mirco Friedrich, Roman Sankowski, Lukas Bunse, Michael Kilian, Edward Green, Carina Ramallo Guevara, Stefan Pusch, Gernot Poschet, Khwab Sanghvi, Markus Hahn, Theresa Bunse, Philipp Münch, Hagen M. Gegner, Jana K. Sonner, Anna von Landenberg, Frederik Cichon, Katrin Aslan, Tim Trobisch, Lucas Schirmer, Denis Abu-Sammour, Tobias Kessler, Miriam Ratliff, Daniel Schrimpf, Felix Sahm, Carsten Hopf, Dieter H. Heiland, Oliver Schnell, Jürgen Beck, Chotima Böttcher, Camila Fernandez-Zapata, Josef Priller, Sabine Heiland, Ilona Gutcher, Francisco J. Quintana, Andreas von Deimling, Wolfgang Wick, Marco Prinz and Michael Platten: Tryptophan metabolism drives dynamic immunosuppressive
myeloid states in IDH-mutant gliomas.
Nature Cancer 2021, DOI: https://www.nature.com/articles/s43018-021-00201-z
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.
Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.
Scientists and clinicians at UCL and Great Ormond Street Hospital (GOSH) studying the effectiveness of CAR T-cell therapies in children with leukaemia, have discovered a small sub-set of T-cells that are likely to play a key role in whether the treatment is successful.
Researchers say 'stem cell memory T-cells' appear critical in both destroying the cancer at the outset and for long term immune surveillance and exploiting this quality could improve the design and performance of CAR T therapies.
Explaining the study, published in Nature Cancer, lead author Dr Luca Biasco (UCL Great Ormond Street Institute of Child Health), said: "During clinical trials we have seen some very encouraging results in young patients with leukaemia, however it's still not clear why CAR T-cells continue ...
A population of bridled nailtail wallabies in Queensland has been brought back from the brink of extinction after conservation scientists led by UNSW Sydney successfully trialled an intervention technique never before used on land-based mammals.
Using a method known as 'headstarting', the researchers rounded up bridled nailtail wallabies under a certain size and placed them within a protected area where they could live until adulthood without the threat of their main predators - feral cats - before being released back into the wild.
In an article published today in Current Biology, the scientists describe how they decided on the strategy to protect only the juvenile wallabies from feral cats in Avocet Nature Refuge, ...
Knowledge systems outside of those sanctioned by Western universities have often been marginalised or simply not engaged with in many science disciplines, but there are multiple examples where Western scientists have claimed discoveries for knowledge that resident experts already knew and shared. This demonstrates not a lack of knowledge itself but rather that, for many scientists raised in Western society, little education concerning histories of systemic oppression has been by design. Western scientific knowledge has also been used to justify social and environmental control, including dispossessing colonised people of their ...
Our brain is usually well protected from uncontrolled influx of molecules from the periphery thanks to the blood-brain barrier, a physical seal of cells lining the blood vessel walls. The hypothalamus, however, is a notable exception to this rule. Characterized by "leaky" blood vessels, this region, located at the base of the brain, is exposed to a variety of circulating bioactive molecules. This anatomical feature also determines its function as a rheostat involved in the coordination of energy sensing and feeding behavior.
Several hormones and nutrients are known to influence the feeding neurocircuit in the hypothalamus. Classic examples are leptin and insulin, both involved in informing the brain of available energy. In the last years, the ...
Skoltech scientists and their colleagues from Germany and the United States have analyzed the metabolomes of humans, chimpanzees, and macaques in muscle, kidney, and three different brain regions. The team discovered that the modern human genome undergoes mutation which makes the adenylosuccinate lyase enzyme less stable, leading to a decrease in purine synthesis. This mutation did not occur in Neanderthals, so the scientists believe that it affected metabolism in brain tissues and thereby strongly contributed to modern humans evolving into a separate species. The research was published in the journal eLife.
The predecessors of modern humans split from their closest evolutionary relatives, Neanderthals and Denisovans, about 600,000 ...
A new low-cost and sustainable technique would boost the possibilities for hospitals and clinics to deliver therapeutics with aerogels, a foam-like material now found in such high-tech applications as insulation for spacesuits and breathable plasters.
With the help of an ordinary kitchen freezer, this newest form of aerogel was made from all natural ingredients, including plant cellulose and algae, says Jowan Rostami, a researcher in fibre technology at KTH Royal Institute of Technology in Stockholm.
Rostami says that the aerogel's low density and favorable surface area make it ideal for a wide range of uses, ...
CHAMPAIGN, Ill. -- Scientists report that it is possible to detect and predict heat damage in crops by measuring the fluorescent light signature of plant leaves experiencing heat stress. If collected via satellite, this fluorescent signal could support widespread monitoring of growth and crop yield under the heat stress of climate change, the researchers say.
Their study measures sun-induced chlorophyll fluorescence - or SIF - to monitor a plant's photosynthetic health and establish a connection between heat stress and crop yield. The findings are published in the journal Global Change Biology.
Sun-induced chlorophyll fluorescence occurs when a portion of photosynthetic energy, in the form of near-infrared light, is emitted from plant leaves, the researchers said.
"There ...
Fifty-six million years ago, as the Earth's climate warmed by five to eight degrees C, new land mammals evolved, tropical forests expanded, giant insects and reptiles appeared and the chemistry of the ocean changed. Through it all, bacteria in the ocean in what is now New Jersey kept a record of the changes in their environment through forming tiny magnetic particles. Now, those particles and their record are all that's left of these microorganisms. Thanks to new research tools, that record is finally being read.
In research published in the journal Paleoceanography and Paleoclimatology, researchers including University of Utah doctoral student Courtney Wagner and associate professor Peter Lippert report the climate clues that can ...
By making a game out of getting their daily steps, new research points to the possibility that people with diabetes could be nudged toward increasing their physical activity, with changes lasting for a full year. Since many now use apps or other digital means to manage their diabetes, this program - which utilized tools like wearable step counters and electronic scales with personalized goals - could potentially be integrated to help individuals achieve greater success. Findings from the study, conducted by a team from the Perelman School of Medicine ...
Carbon is vital to the existence of all living organisms, since it forms the basis of all organic molecules that, in turn, form the basis of all living beings. While that alone is pretty impressive, it has recently found surprisingly novel applications in disciplines such as aerospace and civil engineering with the development of carbon fibers that are stronger, stiffer, and lighter than steel. Consequently, carbon fibers have taken over steel in high-performance products like aircrafts, racecars, and sports equipment.
Carbon fibers are usually combined with other materials to form ...
